Erythromelalgia: a case report and literature review.
OBJECTIVE
Erythromelalgia is a rare condition, of uncertain etiology, characterized by episodic erythema, intense burning pain and warmth of the hands and/or feet, and when chronic, associated with significant disability. The diagnosis is based on a thorough history and physical exam during a painful episode along with diagnostic testing to exclude other causes. This paper describes the unique syndrome of erythromelalgia through a case report and literature review.


METHODS
Case presentation and literature review.


METHODS
A 44-year-old male with erythromelalgia.


CONCLUSIONS
Despite multiple treatment options, erythromelalgia is a challenging disease to effectively manage. Early recognition and treatment may offer patients the best probability of achieving remission or significant improvement.
Buttaci
Charles J
CJ
Department of Physical Medicine and Rehabilitation, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, 30 Bergen Street, Newark, NJ 07101, USA. chuckbuttaci@yahoo.com
D000203:Activities of Daily Living; D000328:Adult; D000588:Amines / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001341:Autonomic Nervous System / Q000503:physiopathology; D001342:Autonomic Nervous System Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*; D001831:Body Temperature / Q000502:physiology; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D015984:Causality; D015897:Comorbidity; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D004916:Erythromelalgia / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*; D015444:Exercise / Q000502:physiology; D005528:Foot / Q000098:blood supply / Q000294:innervation / Q000503:physiopathology*; D000077206:Gabapentin; D006225:Hand / Q000098:blood supply / Q000294:innervation / Q000503:physiopathology*; D006801:Humans; D007036:Hypothermia, Induced / Q000379:methods; D007960:Leukocyte Disorders / Q000150:complications / Q000503:physiopathology; D008297:Male; D008833:Microcirculation / Q000294:innervation / Q000503:physiopathology; D012867:Skin / Q000098:blood supply / Q000294:innervation / Q000503:physiopathology; D017211:Treatment Failure; D014666:Vasomotor System / Q000503:physiopathology; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D000588:Amines; D000928:Antidepressive Agents; D002121:Calcium Channel Blockers; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin